Daxing biopharma cluster shows industrial viability

BEIJING: With government support, Beijing Daxing International Airport Economic Zone is building itself into a major life and health sciences industrial cluster to help propel the country’s biopharmaceutical development.

The economic zone started its construction in September 2019 and covers some 150 square kilometres. By the end of July, registered enterprises in the zone reached 2,961, including 53 foreign companies.

In the life and health sciences sector, there were 231 registered enterprises and eight under-construction projects.

Highlights include projects from State Key Laboratory of Peking Union Medical College Hospital, cell therapy leader Shanghai Cell Therapy Group Co Ltd and Beijing-based stem cell researcher AegleStem Therapeutic.

Li Chengping, an analyst at online healthcare service platform VBData.cn, said one of the reasons for the fast realisation of such a dense population of enterprises was its geographical advantage.

The zone captures the overflow effect from Beijing Daxing International Airport, whose annual passenger count and cargo throughput are estimated to reach 72 million trips and two million tonnes by 2025, he said. — China Daily/ANN

Article type: free
User access status:
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!


Next In Business News

Oil prices fall 2% as Chinese demand worries linger
China investors identify trigger points to buy
More than meets the eye in courier industry
Energy security is global priority in 2023
Asia’s richest man makes US$5bil bet to silence debt-obsessed critics
The crypto bubble of the worst kind
ESG in real estate gains traction
Poll: UK house price rally to end next year but no big crash seen
The rise and fall of FTX
Axiata remains resilient amid challenges

Others Also Read